In contrast, Chu et al. (2007) found that increases in cTnI concentrations were not necessarily predictive of which patients given sunitinib would ultimately develop congestive heart failure or a decline in left ventricular ejection fraction (LVEF). This evidence concerns the gene TNNI3 and congestive heart failure.